I call this meeting to order.
Welcome to meeting number 147 of the House of Commons Standing Committee on Health.
In accordance with our routine motion, I'm informing the committee that all remote participants have completed the required connection tests in advance of the meeting.
Pursuant to Standing Order 108(2), the committee is resuming its study on the subject matter of supplementary estimates (B), 2024-25. We have votes 1b and 5b under the Canadian Food Inspection Agency; votes 1b and 5b under the Canadian Institutes of Health Research; votes 1b, 5b and 10b under the Department of Health; and votes 1b, 5b and 10b under the Public Health Agency of Canada.
I'd like to welcome our panel of witnesses.
We have with us today the Honourable Ya'ara Saks, Minister of Mental Health and Addictions, who has the following officials accompanying her today.
From the Canadian Institutes of Health Research, we have Dr. Tammy Clifford, acting president. From the Department of Health, we have Greg Orencsak, deputy minister; Eric Costen, associate deputy minister; Jennifer Saxe, associate assistant deputy minister of the controlled substances and cannabis branch; and Michelle Boudreau, associate assistant deputy minister of the health policy branch. From the Public Health Agency of Canada, we have Nancy Hamzawi, executive vice-president, and Michael Collins, vice-president of the health promotion and chronic disease prevention branch.
Thank you all for being with us today. Thank you for your patience while we exercised our democratic duty.
Minister, you have the floor. Welcome to the committee.
We have a point of order from Mr. Doherty.